Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis

Strontium ranelate (SrRan) is a drug usually prescribed to treat osteoporosis, with proven effects of decreasing the risk of fractures and an indication of reducing the progression of osteoarthritis (OA). This study aimed to investigate the effects of SrRan as either a prophylactic or a treatment dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, T.A., Sampaio, A.J.B., Nunes, I.D.P., Cartágenes, M.S.S., Garcia, J.B.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572847/
https://www.ncbi.nlm.nih.gov/pubmed/28793056
http://dx.doi.org/10.1590/1414-431X20176314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572847/
https://www.ncbi.nlm.nih.gov/pubmed/28793056
http://dx.doi.org/10.1590/1414-431X20176314

Ejemplares similares